Investors in Cullinan Therapeutics Inc (Symbol: CGEM) saw new options become available today, for the April 2025 expiration. One of the key data points that goes into the price an option buyer is ...
Investors in Cullinan Therapeutics Inc (Symbol: CGEM) saw new options begin trading this week, for the September 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...
Cullinan Oncology, Inc. CGEM announced encouraging interim data from an ongoing phase I/IIa study — Cullinan Pearl — evaluating its sole pipeline candidate, CLN-081, The study is evaluating the safety ...
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and ...
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring ...
On Friday, Merck & Co Inc (NYSE:MRK) agreed to acquire CN201, an investigational clinical-stage bispecific antibody for B-cell-associated diseases, from privately-held Curon Biopharmaceutical. “We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback